His main research concerns Alzheimer's disease, Internal medicine, Biomarker, Pathology and Alzheimer's Disease Neuroimaging Initiative. His Alzheimer's disease research incorporates elements of Neuroimaging, Cerebrospinal fluid, Neuroscience and Dementia, Cognitive decline. His biological study spans a wide range of topics, including Endocrinology, Neurology, Oncology and Cardiology.
His study looks at the intersection of Biomarker and topics like Disease with Clinical trial, Intensive care medicine, Psychiatry, Bioinformatics and Clinical study design. Leslie M. Shaw has researched Pathology in several fields, including Positron emission tomography and Magnetic resonance imaging. In his research, Senile plaques and Neurodegeneration is intimately related to Alzheimer's disease biomarkers, which falls under the overarching field of Alzheimer's Disease Neuroimaging Initiative.
The scientist’s investigation covers issues in Internal medicine, Pathology, Disease, Cerebrospinal fluid and Alzheimer's disease. His Internal medicine study integrates concerns from other disciplines, such as Endocrinology, Neuroimaging and Oncology. Leslie M. Shaw is involved in the study of Pathology that focuses on Atrophy in particular.
His Disease study combines topics in areas such as Clinical trial, Neuroscience and Intensive care medicine. Leslie M. Shaw combines subjects such as Positron emission tomography, Neurodegeneration and Amyloid with his study of Cerebrospinal fluid. Leslie M. Shaw has included themes like Apolipoprotein E and Degenerative disease in his Alzheimer's disease study.
Leslie M. Shaw focuses on Internal medicine, Disease, Cerebrospinal fluid, Oncology and Biomarker. His Internal medicine study combines topics from a wide range of disciplines, such as Cognition, Endocrinology and Neuroimaging. In general Disease, his work in Csf biomarkers and Alzheimer's disease is often linked to Pre analytical linking many areas of study.
His Cerebrospinal fluid research entails a greater understanding of Pathology. The study incorporates disciplines such as Positron emission tomography and Apolipoprotein E in addition to Oncology. His work carried out in the field of Biomarker brings together such families of science as Neurology, Clinical trial and Parkinson's disease.
His primary areas of investigation include Internal medicine, Cerebrospinal fluid, Disease, Biomarker and Pathology. His Internal medicine research incorporates themes from Gastroenterology, Endocrinology, Neuroimaging and Oncology. The concepts of his Cerebrospinal fluid study are interwoven with issues in Frontotemporal dementia, Tau phosphorylation, Reproducibility, Positron emission tomography and Amyloid.
His Alzheimer's disease study, which is part of a larger body of work in Disease, is frequently linked to Clinical Practice, bridging the gap between disciplines. His Biomarker research includes elements of Clinical trial, Neurodegeneration, Immunology, Dementia and Neurology. His research in Pathology focuses on subjects like Magnetic resonance imaging, which are connected to Primary progressive aphasia and Posterior cortical atrophy.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Clifford R Jack;David S Knopman;William J Jagust;Leslie M Shaw.
Lancet Neurology (2010)
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers.
Clifford R Jack;David S Knopman;William J Jagust;Ronald C Petersen.
Lancet Neurology (2013)
Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.
Leslie M. Shaw;Hugo Vanderstichele;Malgorzata Knapik-Czajka;Christopher M. Clark.
Annals of Neurology (2009)
The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception
Michael W. Weiner;Michael W. Weiner;Dallas P. Veitch;Paul S. Aisen;Laurel A Beckett.
Alzheimers & Dementia (2012)
Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization.
R. C. Petersen;P. S. Aisen;Laurel A Beckett;M. C. Donohue.
Activation of Phosphoinositide 3-OH Kinase by the α6β4 Integrin Promotes Carcinoma Invasion
Leslie M Shaw;Isaac Rabinovitz;Helen H.-F Wang;Alex Toker.
Mouse egg integrin α6β1functions as a sperm receptor
Eduardo A. C. Almeida;A. P.J. Huovila;A. E. Sutherland;L. E. Stephens.
Comparing predictors of conversion and decline in mild cognitive impairment
S. M. Landau;Danielle J Harvey;C. M. Madison;E. M. Reiman.
MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers.
N. Schuff;N. Schuff;N. Woerner;L. Boreta;T. Kornfield.
Vascular Endothelial Growth Factor Is an Autocrine Survival Factor for Neuropilin-expressing Breast Carcinoma Cells
Robin E. Bachelder;Aimee Crago;Jun Chung;Melissa A. Wendt.
Cancer Research (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: